Menu

Search

Helen Vassallo

Helen Vassallo

Associate Professor of French and Translation, University of Exeter
My two primary areas of research are literature in translation, and contemporary women's writing in French. My Translating Women research project, launched in 2018, brings together my interests in translated literature and women's writing. The aim of Translating Women is to engage with publishers, translators, booksellers, the media and readers in order to address intersectional gender bias within the publishing industry. This research led to my most recent book, Towards a Feminist Translator Studies: Intersectional Activism in Translation and Publishing (Routledge, October 2022), in which I develop a new critical model that works towards shifting paradigms in the translated literature sector of the publishing industry and presents a positive opportunity to address gender and interconnecting forms of bias. This research was also informed by my work with English PEN on the AHRC-funded network Changing the Landscape: Diversity and Translated Fiction in the UK Publishing Industry. The network brought together publishers, translators and academics to analyse and challenge connected forms of bias in the production and reception of translated fiction.

My recent translation work includes two plays by Darina Al Joundi, The Day Nina Simone Stopped Singing and Marseillaise My Way (both released by Naked Eye Publishing), a collection of short stories and essays by Leïla Slimani, The Devil is in the Detail and other writings (Liverpool University Press, 2023) and Al Joundi's novel Prisoner of the Levant (Liverpool University Press, 2024). I am currently working on several other translation projects, including my role as project co-lead on translations of Ukrainian war poetry.

Other research interests

My early research resulted in two books on French author Jeanne Hyvrard, and highlighted my interest in the literary and autobiographical manifestations of social and physical conflict and trauma. Moving on from this, I began to focus on narratives of war, or of the transmitted legacy of war.

I have published several articles which focus specifically on literature in French which deals with the legacy of the Algerian War of Independence, as well as completing a British Academy-funded monograph titled The Body Besieged: The Embodiment of Historical Memory in Nina Bouraoui and Leïla Sebbar and an article on a previously unpublished text by the actor and playwright Rachid Akbal, written and performed to commemorate the fiftieth anniversary of Algerian independence from France.

My dual interest in gender and narratives of war also links in to my work on Lebanese playwright and actress Darina Al-Joundi, on whose critically acclaimed play Le Jour où Nina Simone a cessé de chanter I have published a number of articles.

1 

Economy

China's Deflationary Woes: CPI and PPI Signal Persistent Economic Challenges

Chinas Consumer Price Index (CPI) dropped 0.1% from year-ago in Chinas Consumer Price Index (CPI) declined 0.1% from a year ago in March 2025, less than Februarys decline of 0.7%. That was lower than an expected rise of...

Trump's Tariff U-Turn: 90-Day Reprieve for Most, China Still in the Crosshairs

On April 2025, Donald Trump announced a 90-day tariff relief for the majority of nations, a dazzling about-turn after imposing them, out of fear of market volatility. This was at a time when global markets were in...

[Editorial Cartoon] “Tariff Chicken Game” – U.S. and China Speed Toward Economic Catastrophe

Amid rising tensions in the U.S.-China trade war, this weeks editorial cartoon depicts a dramatic chicken game scenario, where two economic superpowers appear locked in a collision course with potentially devastating...

Trade War Escalates: China Fires Back with 84% Tariff on US Goods

China escalated the stakes of the trade war with America by imposing an 84% tariff on American products as a retaliatory measure to President Trumps recent tariffs on Chinese products. The retaliatory tariff which...

China's Treasury "Nuclear Option": Bluff or Reality?

If China were to sell its $761 billion in U.S. Treasury bonds, the immediate effects would be higher U.S. Treasury yields, which would rise by 30 to 60 basis points, raising the borrowing cost and cutting economic growth....

Politics

IRS Chief to Resign Amid Controversial Tax Data Sharing Deal with Homeland Security

The acting head of the U.S. Internal Revenue Service (IRS), Melanie Krause, is set to resign following a controversial agreement to share undocumented immigrants tax data with the Department of Homeland Security (DHS),...

Ken Paxton to Challenge Sen. John Cornyn in 2026 Texas GOP Primary

Texas Attorney General Ken Paxton has announced his bid to unseat fellow Republican Senator John Cornyn in the 2026 GOP primary. Speaking on Fox News The Ingraham Angle, Paxton declared his intention to bring stronger...

Trump Slams TSMC Subsidy, Threatens 100% Tax Without U.S. Manufacturing

President Donald Trump criticized the Biden administration for awarding a $6.6 billion subsidy to Taiwan Semiconductor Manufacturing Company (TSMC), arguing that semiconductor giants like TSMC do not need government...

Trump Moves to Block State Climate Laws to Boost Fossil Fuel Industry

U.S. President Donald Trump signed a new executive order on Tuesday aimed at blocking state-level climate laws that restrict fossil fuel use and promote clean energy. This latest move underscores Trumps ongoing efforts to...

Pam Bondi to Lead DOJ Initiative Defending Second Amendment Rights

U.S. Attorney General Pam Bondi is set to spearhead a new Justice Department initiative aimed at protecting gun rights under the Second Amendment, according to a memo reviewed by Reuters. The memo outlines Bondis plan to...

Science

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

What are the chances an asteroid will impact Earth in 2032?

For a few days in mid-February, headlines around the world buzzed about the potential for an asteroid to hit the Earth in 2032 specifically, asteroid 2024 YR4. The chance of this impact rose to a high of 3.1 per cent on...

A new study reveals the structure of violent winds 1,300 light years away

The planet WASP-121b is extreme. Its a gas giant almost twice as big as Jupiter orbiting extremely close to its star50 times closer than the Earth does around the Sun. WASP-121b is so close to its star that tidal forces...

Technology

US Senators Question Microsoft and Google Over AI Cloud Partnerships

Two Democratic U.S. senators are pressing Microsoft (NASDAQ:MSFT) and Google (NASDAQ:GOOGL) for transparency over their cloud computing partnerships with leading artificial intelligence firms. Senators Elizabeth Warren of...

Telegram Fined $80K by Moscow Court for Extremist Content Refusal

A Moscow court has fined Telegram Messenger Inc. 7 million roubles (approximately $80,000) for refusing to remove content allegedly promoting extremist activities, according to Russian state news agency TASS. Court...

Samsung Posts Resilient Q1 Profit on Strong Chip and Smartphone Demand

Samsung Electronics reported a better-than-expected 0.2% drop in Q1 operating profit, reaching 6.6 trillion won ($4.49 billion), beating market forecasts of 5.1 trillion won. This resilience was driven by solid memory chip...

Meta Unveils Llama 4 Maverick and Scout, Boosts AI Ambitions

Meta Platforms (NASDAQ:META) has unveiled its latest AI modelsLlama 4 Maverick and Llama 4 Scoutcalling them its most advanced large language models (LLMs) to date. Designed as multimodal AI systems, they can process and...

Elon Musk’s Lawsuit Against OpenAI Heads to Jury Trial in 2026

Elon Musks high-profile lawsuit against OpenAI is set for a jury trial in spring 2026, as ruled by Judge Yvonne Gonzalez Rogers of the U.S. District Court for the Northern District of California. The case centers on Musks...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.